KOSDAQ large cap
Komipharm International
A pharma developing animal-health products and anticancer and pain therapies. KOSDAQ large-cap constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
041960.KQ Updated Jul 11, 2026 2 AI consumers· 1 recurring
Annual return · 2026-07-10'21-19.3%'22-25.2%'23-31.1%'24-8.5%'25+82.6%YTD+5.2%
Money in ▸·
Komipharm International
▸ Money out·
Financials & Segments
- Segments · Animal pharmaceuticals · Drug development (oncology and pain)
Revenue from
No refined links yet.
Pays to
No refined links yet.